These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7947026)

  • 1. The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients.
    Crocker JF; Renton KW; LeVatte TL; McLellan DH
    Pediatr Nephrol; 1994 Aug; 8(4):408-11. PubMed ID: 7947026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine, verapamil and cyclosporin A pharmacokinetics in children.
    Ogborn MR; Crocker JF; Grimm PC
    Pediatr Nephrol; 1989 Jul; 3(3):314-6. PubMed ID: 2702114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients.
    Sketris IS; Methot ME; Nicol D; Belitsky P; Knox MG
    Ann Pharmacother; 1994 Nov; 28(11):1227-31. PubMed ID: 7849332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant recipients.
    Howard RL; Shapiro JI; Babcock S; Chan L
    Ren Fail; 1990; 12(2):89-92. PubMed ID: 2236731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients.
    Harper SJ; Moorhouse J; Veitch PS; Horsburgh T; Walls J; Bell PR; Donnelly PK; Feehally J
    Transpl Int; 1992; 5 Suppl 1():S69-72. PubMed ID: 14621737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.
    Hammoud SH; Alkhansa S; Mahjoub N; Omar AG; El-Mas MM; Eid AA
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F572-F582. PubMed ID: 29767558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP4A/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats.
    Hammoud SH; Omar AG; Eid AA; El-Mas MM
    Toxicol Appl Pharmacol; 2017 Nov; 334():110-119. PubMed ID: 28899749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients.
    Venkat-Raman G; Feehally J; Elliott HL; Griffin P; Moore RJ; Olubodun JO; Wilkinson R
    Nephrol Dial Transplant; 1998 Oct; 13(10):2612-6. PubMed ID: 9794569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients.
    Renton KW; Crocker JF; McLellan H; Acott PD
    Eur J Clin Pharmacol; 2004 Aug; 60(6):421-6. PubMed ID: 15232662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols.
    Suthanthiran M; Haschemeyer RH; Riggio RR; Adubor C; Friedman GS; Cheigh JS; Wang JC; Fotino M; Stubenbord WT; Saal SD
    Transplantation; 1993 May; 55(5):1008-13. PubMed ID: 8497873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients.
    Tortorice KL; Heim-Duthoy KL; Awni WM; Rao KV; Kasiske BL
    Ther Drug Monit; 1990 Jul; 12(4):321-8. PubMed ID: 2396304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth.
    James JA; Marley JJ; Jamal S; Campbell BA; Short CD; Johnson RW; Hull PS; Spratt H; Irwin CR; Boomer S; Maxwell AP; Linden GJ
    J Clin Periodontol; 2000 Feb; 27(2):109-15. PubMed ID: 10703656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients.
    Thomas DW; Baboolal K; Subramanian N; Newcombe RG
    J Clin Periodontol; 2001 Jul; 28(7):706-9. PubMed ID: 11422595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia.
    Bökenkamp A; Bohnhorst B; Beier C; Albers N; Offner G; Brodehl J
    Pediatr Nephrol; 1994 Apr; 8(2):181-5. PubMed ID: 8018496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A.
    McCulloch TA; Harper SJ; Donnelly PK; Moorhouse J; Bell PR; Walls J; Feehally J; Furness PN
    J Clin Pathol; 1994 Sep; 47(9):839-42. PubMed ID: 7962654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-entry blocking agents in the treatment of systemic hypertension.
    Robinson BF
    Am J Cardiol; 1985 Jan; 55(3):102B-106B. PubMed ID: 2857516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.